The Teva Pharmaceutical Industries Ltd (TEVA) Lowered to Buy at Vetr Inc

The Teva Pharmaceutical Industries Ltd (TEVA) Lowered to Buy at Vetr Inc


Jefferies Group LLC cut shares of Teva Pharmaceutical Industries from a "buy" rating to a "hold" rating and cut their target price for the company from $69.00 to $40.00 in a research note on Sunday, December 4th. BTIG Research downgraded shares of Teva Pharmaceutical Industries from a "buy" rating to a "neutral" rating in a report on Sunday, December 4th.



from Biotech News